title: [Acid related diseases progress in 2007].
abstract: The treatment of reflux disease did not changed. PPI treatment remains the first line treatment and surgery a second line treatment. The effect of surgery in reflux disease reduces and, after ten years, a part of the operated patients needs PPI again. The triple therapy is the treatment of choice of Helicobacter pylori infection. Patients with persistent Helicobacter pylori infection, after a first treatment, should be treated with a sequential treatment. PPI are effective in the prevention of gastroduodenal lesions and in the treatment of dyspeptic symptoms during NSAID treatment. IPP should be given to all patients presenting dyspeptic symptoms under NSAID or COX-2 administration.
authors.affiliation: Service de gastro-entérologie et hépatologie, CHUV, 1011 Lausanne.
authors.forename: Dominique
authors.initials: D
authors.lastname: Vouillamoz
authors.forename: Philippe
authors.initials: P
authors.lastname: Jornod
authors.forename: Francesco
authors.initials: F
authors.lastname: Viani
authors.forename: Cristina
authors.initials: C
authors.lastname: Nichita
authors.forename: Gian
authors.initials: G
authors.lastname: Dorta
mesh_terms: D004942:Esophagitis, Peptic / Q000188:drug therapy / Q000628:therapy*; D005764:Gastroesophageal Reflux / Q000188:drug therapy / Q000628:therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D013272:Stomach Diseases / Q000188:drug therapy / Q000382:microbiology